PublisherAmerican Association for Respiratory Care
MetadataShow full item record
AbstractBACKGROUND: High-flow nasal cannula (HFNC) is increasingly utilized in pediatrics, delivering humidified air and oxygen for respiratory conditions causing hypoxia and distress. In the neonatal ICU, it has been associated with better tolerance, lower complications, and lower cost. Few data exist regarding indications for use and the epidemiology of disease/pathology that warrants HFNC in the pediatric ICU. METHODS: This study is a retrospective cohort study of patients admitted to a tertiary children�s hospital pediatric ICU and placed on HFNC from October 1, 2011 to October 31, 2013. Descriptive statistics were used to describe demographics and utilization data. t test comparisons were used for comparison data. RESULTS: Over the enrollment study period, 620 subjects with HFNC were managed, which represented 27% of total ICU admissions. The average age was 3.74 y (range 0�18.1 y), and subjects were 44% female and 65% African American. Reported primary indications for the utilization of HFNC were status asthmaticus (24%), status asthmaticus with pneumonia (17%), and bronchiolitis (16%). Of the subjects admitted with a primary diagnosis of status asthmaticus, 41% required management with terbutaline. Respiratory viral infections were detected by polymerase chain reaction in 334 subjects managed with HFNC (53.8%) and included 260 subjects testing positive for rhinovirus/enterovirus. When compared with all other respiratory viral illness, subjects with rhinovirus/enterovirus required a higher peak flow (14.9 L vs 13.1 L, P =.01); however, this was an older population, and peak oxygen concentration did not differ between the 2 groups (49.8% vs 47.1%, P =.25). HFNC was used as postextubation support in 16% of the subjects. Of the 63 subjects with congenital heart disease, 92% of the utilization was postextubation. CONCLUSIONS: HFNC was utilized in 27% of all pediatric ICU admissions for a wide range of indications. Development of protocols for the initiation, escalation, and weaning of HFNC would optimize the utilization. Copyright 2017 Daedalus Enterprises.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85046293008&doi=10.4187%2frespcare.05153&partnerID=40&md5=0211196f08b605f2db640d623014f8bb; http://hdl.handle.net/10713/9068
- The use of high-flow nasal cannula (HFNC) as respiratory support in neonatal and pediatric intensive care units in Germany - A nationwide survey.
- Authors: Schmid F, Olbertz DM, Ballmann M
- Issue date: 2017 Oct
- High-flow nasal cannula use in children with respiratory distress in the emergency department: predicting the need for subsequent intubation.
- Authors: Kelly GS, Simon HK, Sturm JJ
- Issue date: 2013 Aug
- High-flow nasal cannula therapy versus non-invasive ventilation in children with severe acute asthma exacerbation: An observational cohort study.
- Authors: Pilar J, Modesto I Alapont V, Lopez-Fernandez YM, Lopez-Macias O, Garcia-Urabayen D, Amores-Hernandez I
- Issue date: 2017 Oct
- Modalities and Complications Associated With the Use of High-Flow Nasal Cannula: Experience in a Pediatric ICU.
- Authors: Baudin F, Gagnon S, Crulli B, Proulx F, Jouvet P, Emeriaud G
- Issue date: 2016 Oct
- Predictive factors for the outcome of high flow nasal cannula therapy in a pediatric intensive care unit: Is the SpO<sub>2</sub>/FiO<sub>2</sub> ratio useful?
- Authors: Kamit Can F, Anil AB, Anil M, Zengin N, Durak F, Alparslan C, Goc Z
- Issue date: 2018 Apr